Treatment of hepatocellular carcinoma

Hepatology

Volumn 25, Issue 2, 1997, Pages 259-262

  Bruix, Jordi ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ANTINEOPLASTIC AGENT; DOXORUBICIN; INTERFERON; IODINATED POPPYSEED OIL; IODINE 131; PLACEBO; TAMOXIFEN;

ARTIFICIAL EMBOLISM; CANCER HORMONE THERAPY; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME;

EID: 0031014484     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250201     Document Type: Review

References (37)

1. Okuda K. Hepatocellular carcinoma: recent progress. HEPATOLOGY 1992;15:948-963.
2. Colombo M, de Franchis R, Del Ninno E, Sangiovanni-A, De-Fazio-C, Tommasini-M, Donato-M-F, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991;325:675-680.
3. Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, Kumada H, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. HEPATOLOGY 1993;18:47-53.
4. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, Nakanishi K, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993;328:797-801.
5. Calvet X, Bruix J, Ginés P, Brú C, Sole M, Vilana R, Rodes J. Prognostic factors of hepatocellular carcinoma in the West. A multivariate analysis in 206 patients. HEPATOLOGY 1990;12:753-760.
6. Makuuchi M. Surgical treatment for hepatocellular carcinoma. In: Arroyo V, Rodes J, Bosch J, eds. Treatments in Hepatology. Barcelona: Mason, 1995:341-352.
7. Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, Visa J, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996;111:1018-1023.
8. Franco D, Capussotti L, Smajda C, Bouzari H, Meakins J, Kemeny F, Grange D, et al. Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis. Gastroenterology 1990;98:733-738.
9. Fuster J, Garcia-Valdecasas JC, Grande L, Tabet J, Bruix J, Anglada T, Taura P, et al. Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series. Ann Surg 1996;223:297-302.
10. Nagasue N, Galizia G, Kohno H, Chang YC, Hayashi T, Yamanoi A, Nakamura T, et al. Adverse effects of preoperative hepatic artery chemoembolization for resectable hepatocellular carcinoma: a retrospective comparison of 138 liver resections. Surgery 1989;106:81-86.
11. Pichlmayr R, Weimann A, Ringe B. Indications for liver transplantation in hepatobiliary malignancy. HEPATOLOGY 1994;20:33S-40S.
12. McPeake JR, O'Grady JG, Zaman S, Portmann B, Wight DG, Tan KC, Calne RY, et al. Liver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome. J Hepatol 1993;18: 226-234.
13. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699.
14. Llovet JM, Bruix J, Fuster J, and the Liver Transplantation Unit. Liver transplantation for hepatocellular carcinoma. Results of a restrictive policy. HEPATOLOGY 1996;24:350A.
15. Boix L, Bruix J, Castells A, Vianney A, Llovet JM, Rivera F, Rodes J. Circulating mRNA for alpha-fetoprotein in patients with hepatocellular carcinoma. Evidence of tumor dissemination after transarterial embolization [Abstract]. HEPATOLOGY 1996;24:349A.
16. Samuel D, Feray C, Bismuth H. Liver transplantation for chronic viral hepatitis. In: Arroyo V, Rodes J, Bosch J, eds. Treatments in Hepatology. Barcelona: Mason, 1995:341-352.
17. Shiina S, Tagawa K, Unuma T, Terano A. Percutaneous ethanol injection therapy for the treatment of hepatocellular carcinoma. AJR 1990; 154:947-951.
18. Vilana R, Bruix J, Brú C, Ayuso MC, Sole M, Rodes J. Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. HEPATOLOGY 1992;16:353-357.
19. Ohnishi K, Nomura F, Ito S, Fujiwara-K. Prognosis of small hepatocellular carcinoma (less than 3 cm) after percutaneous acetic acid injection: study of 91 cases. HEPATOLOGY 1996;23:994-1002.
20. Honda N, Guo Q, Uchida H, Ohishi H, Hiasa Y. Percutaneous hot saline injection therapy for hepatic tumors: an alternative to percutanoeus ethanol injection therapy. Radiology 1994;190:53-57.
21. Seki T, Wakabayashi M, Nakagawa T, Itho T, Shiro T, Kunieda K, Sato M, et al. Ultrasonic ally guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 1994;74:817-825.
22. Castells A, Bruix J, Brú C, Fuster J, Vilana R, Navasa M, Ayuso MC, et al. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. HEPATOLOGY 1993;18:1121-1126.
23. Mondazzi L, Bottelli R, Brambilla G, Rampoldi A, Rezakovic I, Zavaglia C, Albert A, et al. Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. HEPATOLOGY 1994;19:115-1123.
24. Bruix J, Castells A, Montanya X, Calvet X, Bru C, Ayuso MC, Jover L, et al. Phase II study of transarterial embolization in European patients with hepatocellular carcinoma: need for controlled trials. HEPATOLOGY 1994;20:643-650.
25. Kawai S, Okamura J, Ogawa M, Ohashi Y, Tani M, Inoue J, Kawarada Y, et al. Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma - a comparison of lipiodol-transcatheter arterial embolization with and without adriamycin. Cancer Chemother Pharmacol 1992;31:S1-S6.
26. Groupe d'Etude et de Traitament du carcinoma hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995;332:1294-1296.
27. Harris CC, Hollstein M. Clinical implications of the p53 tumor supressor gene. N Engl J Med 1993;329:1318-1327.
28. Kalayci C, Johnson PJ, Raby N, Metivier EM, Williams R. Intraarterial adriamycin and lipiodol for inoperable hepatocellular carcinoma: a comparison with intravenous adriamycin. J Hepatol 1990;11:349-353.
29. Manesis EK, Giannoulis G, Zomboulis P, Vafiadou I, Hadziyannis SJ. Treatment of hepatocellular carcinoma with combined suppression and inhibition of sex hormones: a randomized, controlled trial. HEPATOLOGY 1995;21:1535-1542.
30. Boix L, Castells A, Bruix J, Sole M, Bru C, Fuster J, Rivera F, et al. Androgen receptors in hepatocellular carcinoma: relationship with tumor size and recurrence rate after surgical resection. J Hepatol 1995; 22:616-622.
31. Farinati F, Salvagnini M, de Maria N, Fornasieri A, Chiaramonte M, Rossaro L, Naccarato R. Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifen. J Hepatol 1990;12:297-301.
32. Martinez-Cerezo F, Tomas A, Donoso L, Enriquez J, Guarner C, Balanzo J, Martinez A, et al. Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma. J Hepatol 1994;20:702-706.
33. Castells A, Bruix J, Bru C, Ayuso MC, Roca M, Boix L, Vilana R, et al. Treatment of hepatocellular carcinoma with tamoxifen: a double blind placebo-controlled trial in 120 patients. Gastroenterology 1995;109: 917-922.
34. Takara K, Ohto M, Yoshikawa M, Ebara M, Okuda K, Itami J, Arimizu N. Clinical and pathological study of irradiation therapy in 24 patients with hepatocellular carcinoma. Jpn J Gastroenterol 1986;83:1473-1482.
35. Matsuzaki Y, Osuga T, Saito Y, Chuganji Y, Tanaka N, Shoda J, Tsuji H, et al. A new, effective and safe therapeutic option using proton irradiation for hepatocellular carcinoma. Gastroenterology 1994;106:1032-1041.
36. Raoul JL, Guyader D, Bretagne JF, Duvauferrier R, Bourguet P, Bekhechi D, Deugnier YM, et al. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support. J Nucl Med 1994;35:1782-1787.
37. Lai CL, Lau JYN, Wu PC, Ngan H, Chung HT, Mitchell SJ, Corbett TJ, et al. Recombinant interferon alpha in inoperable hepatocellular carcinoma: a randomized controlled trial. HEPATOLOGY 1993;17:389-394.